Metastatic Breast Cancer

Indianapolis, Indiana, September 18, 2026 Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA)...

BOTHELL, Wash., Aug. 14, 2026 LeonaBio, Inc. reported continued progress in the Phase 3 ELAINE-3 clinical trial evaluating lasofoxifene...

South San Francisco, California, August 13, 2026 Rigel Pharmaceuticals, Inc. announced the U.S. commercial availability of VEPPANU™ (vepdegestrant) for...

BOTHELL, Wash., August 12, 2026 LeonaBio, Inc. announced that its lead investigational therapy lasofoxifene will be featured in multiple...

PARIS, Aug. 4, 2026 Evexta Bio announced a clinical trial collaboration and supply agreement with Roche to evaluate its...

Tokyo, July 24, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products for...

NEW YORK, June 24, 2026 Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved IBRANCE®...

AUSTIN, Texas, June 9, 2026 Zetagen Therapeutics announced preliminary topline results from its Phase 2a clinical study evaluating ZetaMet™...

MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...

SAN DIEGO, Calif., June 1, 2026 Avenzo Therapeutics announced updated clinical results from the Phase 1 portion of its...